Drug Profile
Cx 401
Alternative Names: Cx401; OntarilLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Cellerix
- Developer Axcan Pharma; Cellerix
- Class Mesenchymal stem cell therapies
- Mechanism of Action Cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Rectal fistula
Most Recent Events
- 21 Jun 2011 Discontinued - Phase-III for Rectal fistula in Austria (Intralesional)
- 21 Jun 2011 Discontinued - Phase-III for Rectal fistula in Belgium (Intralesional)
- 21 Jun 2011 Discontinued - Phase-III for Rectal fistula in Czech Republic (Intralesional)